Current Lung Transplant Clinical Trials
For more information about clinical trials at
the Penn Transplant Institute, read our answers
to frequently
asked questions.
A Multicenter prospective cohort
study examining the role of Protein C
(Activated) in early ARDS (biomarkers
of lung injury following transplantation)
Primary Investigator: Jason
D. Christie, MD |
Comparison of a Tacrolimus/Sirolimus/Prednisone
Regimen versus Tacrolimus/Azathioprine/Prednisone
Immunosuppressive Regimen in Lung Transplantation
Primary Investigator: Vivek
N. Ahya, MD |
Laboratory analysis of organ transplant
patients at risk for post transplant
lymphoproliferative disorder (PTLD)
Primary Investigators: Vivek
N. Ahya, MD and Donald
Tsai, MD |
A Double-Blind, Placebo-Controlled,
Multicenter, Dose-Ranging Study of an
Anti-T-lymphocyte Immune Globulin (EZ-2053)
in the Prophylaxis of Acute Pulmonary
Allograft Rejection in Adult Recipients
of Primary Pulmonary Allograft(s)
Primary Investigator: Vivek
N. Ahya, MD |
Phase II Pilot Study of Rituximab
in the Treatment of
Chronic Lung Transplant Rejection (Bronchiolitis Obliterans Syndrome)
Primary Investigators: Vivek
N. Ahya, MD and Donald
Tsai, MD |
Explanted lung acquisition protocol
Principal Investigator: Ellen Pure, PhD
Co-investigator: Pinak
Acharya, MD |
Ventilation and perfusion disturbances
in obliterative bronchiolitis
Principal Investigator: David
Lipson, MD |
|